"10.1371_journal.pone.0050920","plos one","2012-12-27T00:00:00Z","Olivier Nolan-Stevaux; Wendy Zhong; Stacey Culp; Kathy Shaffer; Joseph Hoover; Dineli Wickramasinghe; Astrid Ruefli-Brasse","Oncology Research, Amgen, South San Francisco, California, United States of America; Therapeutic Discovery, Amgen, Seattle, Washington, United States of America","Conceived and designed the experiments: ONS ARB. Performed the experiments: WZ JH. Analyzed the data: WZ JH ONS. Contributed reagents/materials/analysis tools: ONS SC KS. Wrote the paper: ONS. Supervised the research program: ARB DW.","This work was performed at Amgen, solely supported by Amgen, and all authors are employed by Amgen. Monoclonal Rat anti-Human ENG Ab and monoclonal Rat anti-mouse Eng Ab (both developed at Amgen) were used in this study. The authors thank Dyke McEwen for running the first sets of HUVEC tube formation assays at Essen Bioscience. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Olivier Nolan-Stevaux","ONS",7,TRUE,2,2,3,1,TRUE,TRUE,FALSE,0,NA,FALSE
